• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

输血疗法对镰状细胞病和脑血管意外患者一至两年的疗效。

Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents.

作者信息

Wilimas J, Goff J R, Anderson H R, Langston J W, Thompson E

出版信息

J Pediatr. 1980 Feb;96(2):205-8. doi: 10.1016/s0022-3476(80)80803-1.

DOI:10.1016/s0022-3476(80)80803-1
PMID:7351580
Abstract

Since 1974 we have entered 12 children with sickle cell disease and strokes on a transfusion protocol to maintain hemoglobin S less than 20%. Serial arteriography, EEGs, brain or CT scans, and neuropsychologic testing were also obtained. Transfusion has been stopped in ten patients after one to two years. Seven of these ten patients have had second strokes five weeks to 11 months after cessation of transfusion (median three months). Arteriography was normal at the time of the initial stroke in two patients; one of these had a second stroke. Arteriograms did not improve during transfusion therapy. EEGs and brain and CT scans were occasionally useful at the time of the initial stroke but were of little value in following these patients. Neuropsychologic testing indicated severe impairment of sensory-motor and cognitive processes at the time of the initial stroke and was useful in following improvement or deterioration and in designing remedial education programs. We conclude that short-term transfusion therapy will not prevent second strokes once transfusion is stopped and that arteriography is of limited value in these patients.

摘要

自1974年以来,我们已让12名镰状细胞病和中风患儿按照输血方案进行治疗,以将血红蛋白S维持在20%以下。还进行了系列动脉造影、脑电图、脑部或CT扫描以及神经心理学测试。一到两年后,已有10名患者停止输血。这10名患者中有7名在停止输血后5周至11个月(中位时间为3个月)出现了第二次中风。两名患者首次中风时动脉造影正常;其中一人出现了第二次中风。输血治疗期间动脉造影结果并无改善。脑电图以及脑部和CT扫描在首次中风时偶尔有用,但对这些患者的后续跟踪价值不大。神经心理学测试表明,首次中风时感觉运动和认知过程严重受损,有助于跟踪病情改善或恶化情况以及设计补救教育方案。我们得出结论,一旦停止输血,短期输血治疗并不能预防第二次中风,并且动脉造影对这些患者的价值有限。

相似文献

1
Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents.输血疗法对镰状细胞病和脑血管意外患者一至两年的疗效。
J Pediatr. 1980 Feb;96(2):205-8. doi: 10.1016/s0022-3476(80)80803-1.
2
High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease.镰状细胞病患者在停止五至十二年输血治疗后,复发性中风风险高。
J Pediatr. 1991 Mar;118(3):377-82. doi: 10.1016/s0022-3476(05)82150-x.
3
Transfusion therapy for cerebrovascular abnormalities in sickle cell disease.镰状细胞病脑血管异常的输血治疗
J Pediatr. 1976 Mar;88(3):382-7. doi: 10.1016/s0022-3476(76)80251-x.
4
Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.对镰状细胞贫血且经颅多普勒超声检查结果异常的儿童进行输血以预防首次中风
N Engl J Med. 1998 Jul 2;339(1):5-11. doi: 10.1056/NEJM199807023390102.
5
Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease.输血疗法对镰状细胞病血管造影异常及中风复发的影响。
Blood. 1984 Jan;63(1):162-9.
6
Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident.镰状细胞贫血和脑血管意外的低强度长期输血治疗
J Pediatr. 1992 Jan;120(1):54-7. doi: 10.1016/s0022-3476(05)80597-9.
7
The role of transfusion therapy in the treatment of sickle cell disease.输血疗法在镰状细胞病治疗中的作用。
J Intraven Nurs. 1994 Mar-Apr;17(2):70-3.
8
Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease.镰状细胞病中的脑血管意外。危险因素及输血影响。法国镰状细胞病研究小组
Eur J Pediatr. 1993 Mar;152(3):201-4. doi: 10.1007/BF01956144.
9
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.接受红细胞输血治疗的镰状细胞病患者复发性中风的风险。
J Pediatr. 1995 Jun;126(6):896-9. doi: 10.1016/s0022-3476(95)70204-0.
10
Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease.
Stroke. 1994 Aug;25(8):1688-92. doi: 10.1161/01.str.25.8.1688.

引用本文的文献

1
Hydroxyurea for secondary stroke prevention in children with sickle cell anaemia: a systematic review of clinical evidence and outcomes.羟基脲用于镰状细胞贫血患儿继发性中风预防:临床证据与结果的系统评价
Ann Med Surg (Lond). 2024 Jan 3;86(2):1042-1047. doi: 10.1097/MS9.0000000000001660. eCollection 2024 Feb.
2
Molecular and environmental contributors to neurological complications in sickle cell disease.镰状细胞病神经并发症的分子和环境因素。
Exp Biol Med (Maywood). 2023 Aug;248(15):1319-1332. doi: 10.1177/15353702231187646. Epub 2023 Sep 9.
3
Blood Transfusion Vs. Hydroxyurea for Stroke Prevention in Children With Sickle Cell Anemia: A Systematic Review and Meta-Analysis.
输血与羟基脲预防镰状细胞贫血患儿中风的比较:系统评价与荟萃分析
Cureus. 2022 Nov 22;14(11):e31778. doi: 10.7759/cureus.31778. eCollection 2022 Nov.
4
Guidelines on sickle cell disease: secondary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular guidelines project: Associação Médica Brasileira - 2022.镰状细胞病指南:儿童和青少年继发性中风的预防。巴西血液学、血液疗法和细胞治疗协会指南项目:巴西医学协会 - 2022年。
Hematol Transfus Cell Ther. 2022 Apr-Jun;44(2):246-255. doi: 10.1016/j.htct.2022.01.010. Epub 2022 Feb 25.
5
Epidemiology of Stroke in Sickle Cell Disease.镰状细胞病的中风流行病学
J Clin Med. 2021 Sep 18;10(18):4232. doi: 10.3390/jcm10184232.
6
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.输血预防镰状细胞病患者的原发性和继发性中风。
Cochrane Database Syst Rev. 2020 Jul 27;7(7):CD003146. doi: 10.1002/14651858.CD003146.pub4.
7
Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.镰状细胞病中的血管不稳定与神经病变:一个综合框架
Front Neurol. 2019 Aug 13;10:871. doi: 10.3389/fneur.2019.00871. eCollection 2019.
8
Higher executive abilities following a blood transfusion in children and young adults with sickle cell disease.输血可提高镰状细胞病患儿及青年成年人的高级执行能力。
Pediatr Blood Cancer. 2019 Oct;66(10):e27899. doi: 10.1002/pbc.27899. Epub 2019 Jul 3.
9
Differences in Activation and Deactivation in Children with Sickle Cell Disease Compared with Demographically Matched Controls.与人口统计学匹配的对照组相比,镰状细胞病患儿激活和失活的差异。
AJNR Am J Neuroradiol. 2017 Jun;38(6):1242-1247. doi: 10.3174/ajnr.A5170. Epub 2017 Apr 13.
10
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.输血预防镰状细胞病患者的原发性和继发性中风
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD003146. doi: 10.1002/14651858.CD003146.pub3.